As already mentioned above, inhibition of BRD2 and BRD4 by CPI203 and JQ1 could also inhibit the oncogenic NF-κB activity and kill ABC-DLBCL cells [239]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.